3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
5
Radiation Injuries
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Glioma
1
Glioblastoma
1
Fatigue
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
66
Radiotherapy
34
Carboplatin
22
Carmustine
21
Bevacizumab
21
Irinotecan
18
Filgrastim
18
Surgical Procedures, Operative
14
Vincristine
11
Peripheral Blood Stem Cell Transplantation
11
Etoposide
11
Radiation
10
O(6)-benzylguanine
10
Magnetic Resonance Spectroscopy
9
Lomustine
9
Procarbazine
8
Erlotinib Hydrochloride
8
sargramostim
7
IL13-PE38
7
Everolimus
7
Cyclophosphamide
7
Chemotherapy, Adjuvant
7
Thiotepa
6
Radiotherapy, Intensity-Modulated
6
Imatinib Mesylate
6
Granulocyte Colony-Stimulating Factor
6
Drug Therapy
6
Cisplatin
6
temsirolimus
5
antineoplaston AS 2-1
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Astrocytoma
×
Neuropsychological Tests
×
Clear all
NCT02903784
2020-09-02
BNL
University Hospital, Montpellier
Phase NA
Completed
63 enrolled